| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Apr―25 |
Curcumin-Based Virtual Screening Identifies Inhibitors of SARS-CoV-2 Spike Protein and ACE2 Receptor Binding |
Timoteo Delgado-Maldonado, Luis D. Gonzalez-Morales, Gilberto Vargas-Salas, Guadalupe Rojas-Verde, Eyra Ortíz-Pérez, Alma D. Paz-Gonzalez, Gildardo Rivera |
| 2 |
[GO] |
2024―Nov―29 |
Identification of Potential FDA-Approved Inhibitors of SARS-CoV-2 Helicase Through a Multistep In Silico Approach: A Promising Prospect for COVID-19 Treatment |
Ibrahim H. Eissa, Eslam B. Elkaeed, Alaa Elwan, Aisha A. Alsfouk, Ahmed M. Metwaly |
| 3 |
[GO] |
2024―Jul―23 |
Chemically Synthesized 1,2,3,4,6-Pentakis-O-Galloyl-β-D-Glucopyranoside
Blocks SARS-CoV-2 Spike Interaction with Host ACE-2 Receptor |
Jazmine Ezell, Rami A. Al-Horani |
| 4 |
[GO] |
2024―Feb―03 |
Systematic Review On Major Antiviral Phytocompounds from Common
Medicinal Plants Against SARS-CoV-2 |
Suvendu Ghosh, Partha Singha, Lakshmi Kanta Das, Debosree Ghosh |
| 5 |
[GO] |
2024―Jan―11 |
Structure-based Virtual Screening from Natural Products as Inhibitors of
SARS-CoV-2 Spike Protein and ACE2-h Receptor Binding and their
Biological Evaluation In vitro |
Timoteo Delgado-Maldonado, Luis Donaldo Gonzalez-Morales, Alfredo Juarez-Saldivar, Edgar E. Lara-Ramírez, Guadalupe Rojas-Verde, Adriana Rodriguez-Moreno, et al. (+2) Debasish Bandyopadhyay, Gildardo Rivera |
| 6 |
[GO] |
2023―Nov―10 |
Determination of Novel SARS-CoV-2 Inhibitors by Combination of
Machine Learning and Molecular Modeling Methods |
Ersin Güner, Özgür Özkan, Gözde Yalcin Ozkat, Süreyya Ölgen |
| 7 |
[GO] |
2023―Apr―18 |
An in silico investigation to identify promising inhibitors for SARS-CoV-2 Mpro target |
V. Alagarsamy, P. Shyam Sundar, B. Narendhar, M. T. Sulthana, Vishaka S. Kulkarni, A. Dharshini Aishwarya, et al. (+5) V. Raja Solomon, S. Murugesan, S. Jubie, K. Rohitha, Sangeetha Dhanwar |
| 8 |
[GO] |
2023―Feb―28 |
Recent Advances in N-Heterocycles for COVID-19 Treatment- A Mini Review |
Monica Dinodia |
| 9 |
[GO] |
2022―Okt―18 |
The Coronavirus Epidemic |
A. Hilgeroth |
| 10 |
[GO] |
2022―Okt―12 |
Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2? |
Igor José dos Santos Nascimento, Ricardo Olimpio de Moura |
| 11 |
[GO] |
2022―Aug―30 |
An Insight into COVID-19 and Traditional Herbs: Bangladesh Perspective |
Abdur Rauf, Md. Mominur Rahman, Sheikh Shohag, Md. Rezaul Islam, Shomaya Akhter, Sadia Afsana Mim, Rohit Sharma |
| 12 |
[GO] |
2022―Jun―17 |
Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in Development of COVID-19 |
Lok Yong Hui, Chan Sook Mun, Lai Cong Sing, Harish Rajak, Rohini Karunakaran, Veerasamy Ravichandran |
| 13 |
[GO] |
2022―Feb―14 |
Recent Development of Small Molecules for SARS-CoV-2 and the Opportunity for Fragment-Based Drug Discovery |
Sujit Mahato |
| 14 |
[GO] |
2021―Aug―09 |
Structural bioinformatics used to predict the protein targets of remdesivir and flavones in SARS-CoV-2 infection |
Avram Speranta, Laura Manoliu, Catalina Sogor, Maria Mernea, Corina Duda Seiman, Daniel Duda Seiman, Carmen Chifiriuc |
| 15 |
[GO] |
2021―Jun―21 |
Discovery of a “Cocktail” of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. (“Lagundi”) |
Ruel Cayona, Evelyn Creencia |
| 16 |
[GO] |
2021―Feb―10 |
Coumarins and Quinolones as Effective Multiple Targeted Agents Versus Covid-19: An in Silico Study |
Mojgan Nejabat, Razieh Ghodsi, Farzin Hadizadeh |
| 17 |
[GO] |
2020―Jul―28 |
In silico study to evaluate the antiviral activity of novel structures against 3C-like protease of Novel Coronavirus (COVID-19) and SARS-CoV |
Kiran Chunduru, Runali Sankhe, Farmiza Begum, Nalini Sodum, Nitesh Kumar, Anoop Kishore, et al. (+3) Rekha R. Shenoy, C. Mallikarjuna Rao, Kavitha Saravu |
| 18 |
[GO] |
2020―Apr―18 |
The Coronavirus Epidemic |
A. Hilgeroth |
